ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Boehringer Ingelheim and Weill Cornell Medicine are joining to discover new approaches to treating chronic obstructive pulmonary disease. The three-year collaboration is intended to combine Weill Cornell’s understanding of chronic airway diseases with Boehringer’s expertise in discovering therapies for respiratory disease. The two organizations earlier collaborated on inflammatory bowel disease.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter